Alzheimer’s Disease: Pathophysiology and Applications of Magnetic Nanoparticles as MRI Theranostic Agents
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is the most common form of dementia. During the recent decade, nanotechnology has been widely considered, as a promising tool, for theranosis (diagnosis and therapy) of AD. Here we first discuss pathophysiology and characteristics of AD with a focus on the amyloid cascade hypothesis. Then magnetic nanoparticles (MNPs) and recent works on their applications in AD, focusing on the superparamagnetic iron oxide nanoparticles (SPIONs), are reviewed. Furthermore, the amyloid-nanoparticle interaction is highlighted, with the scope to be highly considered by the scientists aiming for diagnostics and/or treatment of AD employing nanoparticles. Furthermore, recent findings on the "ignored" parameters (e.g., effect of protein "corona" at the surface of nanoparticles on amyloid-β (Aβ) fibrillation process) are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Protein folding and misfolding
Dobson, C. M. (2003) · Nature · doi:10.1038/nature02261 · Cited by 4,791
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Monopoli, M. P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., & Dawson, K. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107583h · Cited by 1,835
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618
Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus
Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L. (1987) · Science · doi:10.1126/science.2949367 · Cited by 1,611
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Trafficking and Proteolytic Processing of APP
Haass, C., Kaether, C., Thinakaran, G., & Sisodia, S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006270 · Cited by 1,075
Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
Mucke, L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006338 · Cited by 1,000
Holtzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050004797 · Cited by 937
El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915
Jin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D., & Selkoe, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017033108 · Cited by 876
Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
Dodart, J.-C., Bales, K. R., Gannon, K. S., Greene, S. J., DeMattos, R. B., Mathis, C., DeLong, C. A., Wu, S., Wu, X., Holtzman, D. M., et al. (2002) · Nature Neuroscience · doi:10.1038/nn842 · Cited by 858
apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771
Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600948103 · Cited by 701
Delivery of therapeutic agents to the central nervous system: the problems and the possibilities
Begley, D. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.001 · Cited by 679
Bell, R. D., Sagare, A. P., Friedman, A. E., Bedi, G. S., Holtzman, D. M., Deane, R., & Zlokovic, B. V. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600419 · Cited by 670
Lemere, C. A., Blusztajn, J. K., Yamaguchi, H., Wisniewski, T., Saido, T. C., & Selkoe, D. J. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0003 · Cited by 584
Isoform-specific binding of apolipoprotein E to beta-amyloid.
LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., & Frail, D. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31529-6 · Cited by 540
Xu, Q., Bernardo, A., Walker, D., Kanegawa, T., Mahley, R. W., & Huang, Y. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5476-05.2006 · Cited by 524
Resolving controversies on the path to Alzheimer's therapeutics
Selkoe, D. J. (2011) · Nature Medicine · doi:10.1038/nm.2460 · Cited by 494
Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein
Polvikoski, T., Sulkava, R., Haltia, M., Kainulainen, K., Vuorio, A., Verkkoniemi, A., Niinistö, L., Halonen, P., & Kontula, K. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331902 · Cited by 493
ApoE-4 and Age at Onset of Alzheimer's Disease: The NIMH Genetics Initiative
Blacker, D., Haines, J. L., Rodes, L., Terwedow, H., Go, R. C. P., Harrell, L. E., Perry, R. T., Bassett, S. S., Chase, G., Meyers, D., et al. (1997) · Neurology · doi:10.1212/wnl.48.1.139 · Cited by 479
Xie, J., Brayne, C., & Matthews, F. E. (2008) · BMJ · doi:10.1136/bmj.39433.616678.25 · Cited by 438
Correlations of synaptic and pathological markers with cognition of the elderly
Dickson, D. W., Crystal, H. A., Bevona, C., Honer, W., Vincent, I., & Davies, P. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00013-5 · Cited by 410
19F and 1H MRI detection of amyloid β plaques in vivo
Higuchi, M., Iwata, N., Matsuba, Y., Sato, K., Sasamoto, K., & Saido, T. C. (2005) · Nature Neuroscience · doi:10.1038/nn1422 · Cited by 339
Course of cerebral amyloid angiopathy–related inflammation
Kinnecom, C., Lev, M. H., Wendell, L., Smith, E. E., Rosand, J., Frosch, M. P., & Greenberg, S. M. (2007) · Neurology · doi:10.1212/01.wnl.0000260066.98681.2e · Cited by 333
Olfactory Dysfunction Correlates with Amyloid-β Burden in an Alzheimer's Disease Mouse Model
Wesson, D. W., Levy, E., Nixon, R. A., & Wilson, D. A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4622-09.2010 · Cited by 290
Engineered nanoparticles for biomolecular imaging
Mahmoudi, M., Serpooshan, V., & Laurent, S. (2011) · Nanoscale · doi:10.1039/c1nr10326a · Cited by 262
Aβ-peptides enhance vasoconstriction in cerebral circulation
Niwa, K., Porter, V. A., Kazama, K., Cornfield, D., Carlson, G. A., & Iadecola, C. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.6.h2417 · Cited by 202
Stranahan, A. M., & Mattson, M. P. (2010) · Neural Plasticity · doi:10.1155/2010/108190 · Cited by 198
Laurent, S., Burtea, C., Thirifays, C., Häfeli, U. O., & Mahmoudi, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029997 · Cited by 171
Grehan, S., Tse, E., & Taylor, J. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-03-00812.2001 · Cited by 138
Yang, J., Zaim Wadghiri, Y., Minh Hoang, D., Tsui, W., Sun, Y., Chung, E., Li, Y., Wang, A., de Leon, M., & Wisniewski, T. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.01.023 · Cited by 135
Mechanisms of Mononuclear Phagocyte Recruitment in Alzheimers Disease
Hickman, S. E., & Khoury, J. E. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791011982 · Cited by 120
Tourdias, T., Roggerone, S., Filippi, M., Kanagaki, M., Rovaris, M., Miller, D. H., Petry, K. G., Brochet, B., Pruvo, J.-P., Radüe, E.-W., et al. (2012) · Radiology · doi:10.1148/radiol.12111416 · Cited by 85
Ito, S., Ohtsuki, S., Kamiie, J., Nezu, Y., & Terasaki, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04938.x · Cited by 85
Research works printed but not linked: 116
- Selkoe D. J., 2003, Annu. Rev. Pharmacol. Toxicol., 43, 545, 10.1146/annurev.pharmtox.43.100901.140248 · DOI · Paper page
- Mahmoudi M., 2012, Chem. Commun., 48, 3957, 10.1039/c2cc30213f · DOI
- Mahmoudi M., 2012, ACS Nano, 6, 2656, 10.1021/nn300042m · DOI · Paper page
- Helzner E. P., 2008, Neurology, 71, 1489, 10.1212/01.wnl.0000334278.11022.42 · DOI · Paper page
- Folstein M. F., 1975, J. Psychiatr. Res., 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
- Berger G., 2008, J. Geriatr. Psychiatry Neurol., 21, 250, 10.1177/0891988708324939 · DOI
- Wilson R. S., 2006, Neuroepidemiology, 26, 61, 10.1159/000090250 · DOI · Paper page
- Mahmoudi M., 2012, Trends Biotechnol., 30, 609, 10.1016/j.tibtech.2012.08.007 · DOI
- Van Dam D., 2006, Nat. Rev. Drug Discovery, 5, 956, 10.1038/nrd2075 · DOI · Paper page
- Allinson T. M., 2003, J. Neurosci. Res., 74, 342, 10.1002/jnr.10737 · DOI · Paper page
- Wisniewski T., 2010, Biochim. Biophys. Acta, Mol. Basis Dis., 1802, 847, 10.1016/j.bbadis.2010.05.004 · DOI · Paper page
- Weller R. O., 2003, Neurol. Res., 25, 611, 10.1179/016164103101202057 · DOI · Paper page
- Maat-Schieman M., 2005, Neuropathology, 25, 288, 10.1111/j.1440-1789.2005.00631.x · DOI · Paper page
- Crawford F., 1998, Exp. Neurol., 150, 159, 10.1006/exnr.1997.6743 · DOI
- Niwa K., 2001, Am. J. Physiol.: Heart Circ. Physiol., 281, H2417
- de la Torre J. C., 2000, Neurobiol. Aging, 21, 331, 10.1016/S0197-4580(00)00111-1 · DOI · Paper page
- Crawford F., 1998, FEBS Lett., 436, 445, 10.1016/S0014-5793(98)01170-3 · DOI · Paper page
- Thomas T., 1997, J. Cardiovasc. Pharmacol., 30, 517, 10.1097/00005344-199710000-00017 · DOI
- Burke S. N., 2010, Trends Neurosci., 33, 153, 10.1016/j.tins.2009.12.003 · DOI · Paper page
- Samuel W., 1994, Neurology, 44, 2081, 10.1212/WNL.44.11.2081 · DOI · Paper page
- Rapp P. R., 1996, Proc. Natl. Acad. Sci. U.S.A., 93, 9926, 10.1073/pnas.93.18.9926 · DOI · Paper page
- Dong H., 2007, J. Comp. Neurol., 500, 311, 10.1002/cne.21176 · DOI · Paper page
- Rademakers R., 2003, Sci. World J., 3, 497, 10.1100/tsw.2003.39 · DOI · Paper page
- Tanzi R. E., 2001, Neuron, 32, 181, 10.1016/S0896-6273(01)00476-7 · DOI · Paper page
- Mayeux., 2003, Annu. Rev. Neurosci., 26, 81, 10.1146/annurev.neuro.26.043002.094919 · DOI · Paper page
- Van Duijn C. M., 1994, Genet. Epidemiol., 11, 539, 10.1002/gepi.1370110609 · DOI · Paper page
- Corder E. H., 1993, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
- Strittmatter W. J., 1993, Proc. Natl. Acad. Sci. U.S.A., 90, 1977, 10.1073/pnas.90.5.1977 · DOI · Paper page
- Pitas R. E., 1987, J. Biol. Chem., 6, 63
- Xu P. T., 1999, Neurobiol. Dis., 6, 63, 10.1006/nbdi.1998.0213 · DOI · Paper page
- Mahley R. W., 2000, Annu. Rev. Genomics Hum. Genet., 1, 507, 10.1146/annurev.genom.1.1.507 · DOI · Paper page
- Tierney M. C., 1996, Neurology, 46, 149, 10.1212/WNL.46.1.149 · DOI · Paper page
- Mahley R. W., 2006, Proc. Natl. Acad. Sci. U.S.A., 103, 5644, 10.1073/pnas.0600549103 · DOI · Paper page
- McLean C. A., 1999, Ann. Neurol., 46, 860, 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
- Hardy J., 2002, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
- Li S., 2009, Neuron, 62, 788, 10.1016/j.neuron.2009.05.012 · DOI · Paper page
- Glenner G. G., 1984, Biochem. Biophys. Res. Commun., 120, 885, 10.1016/S0006-291X(84)80190-4 · DOI · Paper page
- Glenner G. G., 1989, Prog. Clin. Biol. Res., 317, 857
- Ikeda S., 1989, Lab. Invest., 60, 113
- Goldgaber D., 1987, Science, 235, 877, 10.1126/science.3810169 · DOI · Paper page
- St George-Hyslop P. H., 1987, Science, 235, 885, 10.1126/science.2880399 · DOI · Paper page
- Levy E., 1990, Science, 248, 1124, 10.1126/science.2111584 · DOI · Paper page
- Selkoe D. J., 1998, Trends Cell Biol., 8, 447, 10.1016/S0962-8924(98)01363-4 · DOI · Paper page
- Bonifacino J. S., 2003, Annu. Rev. Biochem., 72, 395, 10.1146/annurev.biochem.72.121801.161800 · DOI · Paper page
- Yamazaki T., 1996, J. Cell Sci., 109, 999, 10.1242/jcs.109.5.999 · DOI · Paper page
- Koo E. H., 1996, J. Cell Sci., 109, 991, 10.1242/jcs.109.5.991 · DOI · Paper page
- Stokin G. B., 2006, Annu. Rev. Biochem., 75, 607, 10.1146/annurev.biochem.75.103004.142637 · DOI · Paper page
- Tienari P., 1996, EMBO J., 15, 10.1002/j.1460-2075.1996.tb00907.x · DOI
- Roychaudhuri R., 2009, J. Biol. Chem., 284, 4749, 10.1074/jbc.R800036200 · DOI · Paper page
- Bernstein S. L., 2009, Nat. Chem., 1, 326, 10.1038/nchem.247 · DOI · Paper page
- Colletier J. P., 2011, Proc. Natl. Acad. Sci. U.S.A., 108, 16938, 10.1073/pnas.1112600108 · DOI · Paper page
- Rahimi F., 2008, Curr. Alzheimer Res., 5, 319, 10.2174/156720508784533358 · DOI · Paper page
- Sakono M., 2010, FEBS J., 277, 1348, 10.1111/j.1742-4658.2010.07568.x · DOI · Paper page
- Lasagna-Reeves C. A., 2011, J. Biol. Chem., 286, 22122, 10.1074/jbc.M111.236257 · DOI · Paper page
- Glabe C. G., 2006, Neurology, 66, S74, 10.1212/01.wnl.0000192103.24796.42 · DOI · Paper page
- Williams R., 2001, Coord. Chem. Rev., 216, 583, 10.1016/S0010-8545(00)00398-2 · DOI · Paper page
- Laurent S., 2012, RSC Adv., 2, 5008, 10.1039/c2ra01374f · DOI
- 10.1038/srep02782 · DOI
- Tottey S., 2007, Molecular microbiology of heavy metals
- Chamberlain R., 2009, Magn. Reson. Med., 61, 1158, 10.1002/mrm.21951 · DOI · Paper page
- Zerbi V., 2012, Brain Struc. Funct., 218, 1805
- Fazil M., 2012, J. Drug Targeting, 20, 97, 10.3109/1061186X.2011.607499 · DOI
- Gabathuler R., 2010, Neurobiol. Dis., 37, 48, 10.1016/j.nbd.2009.07.028 · DOI · Paper page
- Roney C., 2005, J. Controlled Release, 108, 193, 10.1016/j.jconrel.2005.07.024 · DOI · Paper page
- Tanifum E. A., 2012, PloS One, 7, e48515, 10.1371/journal.pone.0048515 · DOI · Paper page
- Beckmann N., 2011, J. Neurosci., 31, 1023, 10.1523/JNEUROSCI.4936-10.2011 · DOI · Paper page
- Petiet A., 2012, Neurobiol. Aging, 33, 1533, 10.1016/j.neurobiolaging.2011.03.009 · DOI
- Poduslo J. F., 2002, Neurobiol. Dis., 11, 315, 10.1006/nbdi.2002.0550 · DOI · Paper page
- Sillerud L. O., 2013, J. Alzheimer’s Dis., 34, 349, 10.3233/JAD-121171 · DOI · Paper page
- Cai W., 2007, Small, 3, 1840, 10.1002/smll.200700351 · DOI · Paper page
- Cao C. Y., 2013, Sci. Rep., 3, 1024, 10.1038/srep01024 · doi:10.1038/srep01024
- Kanal E., 2012, Magn. Reson. Imaging Clin. North Am., 20, 625, 10.1016/j.mric.2012.08.004 · doi:10.1016/j.mric.2012.08.004
- Othman M., 2011, Org. Biomol. Chem., 9, 4367, 10.1039/c1ob00015b · doi:10.1039/c1ob00015b
- Laurent S., 2004, Bioconjugate Chem., 15, 99, 10.1021/bc034114m · doi:10.1021/bc034114m
- Amiri H., 2011, Magn. Reson. Med., 66, 1715, 10.1002/mrm.22959 · DOI
- Amiri H., 2011, Nanoscale, 3, 1022, 10.1039/C0NR00603C · DOI · Paper page
- Hosseini F., 2013, Colloids Surf., B, 652, 10.1016/j.colsurfb.2012.10.035 · doi:10.1016/j.colsurfb.2012.10.035
- Wang Y. X., 2011, Quant. Imaging Med. Surg., 1, 35
- Yanagisawa D., 2011, Neuroscience, 184, 120, 10.1016/j.neuroscience.2011.03.071 · DOI
- Houshang Amiri, M. S., Andor Veltein, Mark J., van Uden, I., Jolanda, M., and de Vries, Arend Heerschap. (2013) Cell Tracking by 19F MRI:Technical Aspects and Challenges towards Clinical Applications.Submitted for publication. · DOI
- Krol S., 2013, Chem. Rev., 113, 1877, 10.1021/cr200472g · DOI · Paper page
- Mahmoudi M., 2013, ACS Chem. Neurosci., 4, 475, 10.1021/cn300196n · DOI · Paper page
- Cabaleiro-Lago C., 2010, ACS Chem. Neurosci., 1, 279, 10.1021/cn900027u · DOI · Paper page
- Amiri H., 2013, Nanoscale, 5, 8656, 10.1039/c3nr00345k · DOI · Paper page
- Dorota Walczyk B. F., 2010, J. Am. Chem. Soc., 5761
- Mahmoudi M., 2011, Chem. Rev., 111, 5610, 10.1021/cr100440g · DOI · Paper page
- Lesniak A., 2012, ACS Nano, 6, 5845, 10.1021/nn300223w · DOI · Paper page
- Mahmoudi M., 2013, ChemBioChem, 14, 568, 10.1002/cbic.201300007 · DOI
- Mahmoudi M., 2012, Nanoscale, 4, 7322, 10.1039/c2nr31657a · DOI · Paper page
- Mahmoudi M., 2013, ACS Nano, 7, 6555, 10.1021/nn305337c · DOI · Paper page
- Ghavami M., 2013, ACS Chem. Neurosci., 4, 375, 10.1021/cn300205g · DOI
- Mahmoudi M., 2011, ACS Nano, 5, 7263, 10.1021/nn2021088 · DOI · Paper page
- Laurent S., 2013, J. Colloid Interface Sci., 392, 431, 10.1016/j.jcis.2012.10.005 · DOI
- Rauch J., 2012, Sci. Rep., 2, 868, 10.1038/srep00868 · DOI
- Mahmoudi M., 2012, Nanoscale, 4, 5461, 10.1039/c2nr31185b · DOI
- Mahmoudi M., 2011, Chem. Rev., 111, 253, 10.1021/cr1001832 · DOI · Paper page
- Mahmoudi M., 2010, Int. J. Biomed. Nanosci. Nanotechnol., 164, 10.1504/IJBNN.2010.034651 · DOI · Paper page
- Mahmoudi M., 2010, J. Iran. Chem. Soc., 7, S1, 10.1007/BF03246181 · DOI
- Nighoghossian N., 2007, Stroke, 38, 303, 10.1161/01.STR.0000254548.30258.f2 · DOI · Paper page
- Saleh A., 2007, Stroke, 38, 2733, 10.1161/STROKEAHA.107.481788 · DOI · Paper page
- Dousset V., 2006, AJNR Am. J. Neuroradiol., 27, 1000
- Mahmoudi M., 2011, ACS Chem. Neurosci., 2, 118, 10.1021/cn100100e · DOI · Paper page
- Mahmoudi M., 2011, Adv. Drug Delivery Rev., 63, 24, 10.1016/j.addr.2010.05.006 · DOI · Paper page
- Mahmoudi M, 2010, Superparamagnetic iron oxide nanoparticles for biomedical applications
- Brambilla D., 2012, ACS Nano, 6, 5897, 10.1021/nn300489k · DOI · Paper page
- Skaat H., 2009, Nanotechnology, 20, 225106, 10.1088/0957-4484/20/22/225106 · DOI
- Skaat H., 2009, Biochem. Biophys. Res. Commun., 386, 645, 10.1016/j.bbrc.2009.06.110 · DOI
- Skaat H., 2009, J. Biomed. Mater. Res., Part A, 91, 342, 10.1002/jbm.a.32232 · DOI
- Andersson B. V., 2012, Biochem. Biophys. Res. Commun., 419, 682, 10.1016/j.bbrc.2012.02.077 · DOI
- Bellova A., 2010, Nanotechnology, 21, 065103, 10.1088/0957-4484/21/6/065103 · DOI
- Mahmoudi M., 2012, Chem. Rev., 112, 2323, 10.1021/cr2002596 · DOI · Paper page
- Conti B., 2013, Cell, 152, 671, 10.1016/j.cell.2013.01.050 · DOI
- Xiao R., 2013, Cell, 152, 806, 10.1016/j.cell.2013.01.020 · DOI · Paper page
- Vinters H. V., 1998, Acta Neuropathol., 95, 235, 10.1007/s004010050793 · DOI
- Deng Z. J., 2011, Nature Nanotechnol., 6, 39, 10.1038/nnano.2010.250 · DOI · Paper page
- Ahn H. J., 2010, Proc. Natl. Acad. Sci. U.S.A., 107, 21812, 10.1073/pnas.1010373107 · DOI · Paper page
Cited by
Tau-Targeted Multifunctional Nanocomposite for Combinational Therapy of Alzheimer’s Disease
Chen, Q., Du, Y., Zhang, K., Liang, Z., Li, J., Yu, H., Ren, R., Feng, J., Jin, Z., Li, F., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b07625 · Cited by 280
“IONCs were used as high-resolution magnetic resonance imaging (MRI) agents for AD.(31-36) Furthermore, methylene blue (MB),(37-40) a small molecular compound inhibiting tau aggregation was loaded into the pores of MSNs.”
MethodNeurotheranostics as Personalized Medicines
Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124
Wang, Z., Hu, J., Yang, X., Feng, X., Li, X., Huang, L., & Chan, A. S. C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01417 · Cited by 91
La Barbera, L., Mauri, E., D’Amelio, M., & Gori, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.939855 · Cited by 74
Liu, D., Li, W., Jiang, X., Bai, S., Liu, J., Liu, X., Shi, Y., Kuai, Z., Kong, W., Gao, R., et al. (2019) · Theranostics · doi:10.7150/thno.30649 · Cited by 49
Metadata
- Authors
- Amiri, H., Saeidi, K., Borhani, P., Manafirad, A., Ghavami, M., & Zerbi, V.
- Venue
- ACS Chemical Neuroscience
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-09-26
- Volume
- 4
- Issue
- 11
- Pages
- 1417-1429
- ISSN
- 1948-7193 (ISSN-L)
- OpenAlex
- W2064534908
- Cited by
- 113
- References
- 50
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.